US 9,808,435 B2
Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
Daniel E. Pedersen, Cottage Grove, MN (US); Hilina Emiru, Rosemount, MN (US); and Carter Martin Silvernail, Burnsville, MN (US)
Assigned to Ecolab USA Inc., Saint Paul, MN (US)
Filed by Ecolab USA Inc., St. Paul, MN (US)
Filed on Mar. 12, 2013, as Appl. No. 13/795,219.
Prior Publication US 2014/0275255 A1, Sep. 18, 2014
Int. Cl. A61K 8/365 (2006.01); C11D 1/00 (2006.01); A01N 37/00 (2006.01); A61K 31/19 (2006.01); A01N 31/02 (2006.01); A01N 37/36 (2006.01); A61K 31/045 (2006.01); A61K 31/20 (2006.01)
CPC A61K 31/19 (2013.01) [A01N 31/02 (2013.01); A01N 37/36 (2013.01); A61K 31/045 (2013.01); A61K 31/20 (2013.01)] 6 Claims
 
1. An antiviral use solution having antimicrobial activity against non-enveloped viruses including norovirus where the use solution comprises: from 30 weight percent to 99 weight percent ethanol; from 0.5 weight percent to 2 weight percent of an alkyl 2-hydroxycarboxylic acid wherein said alkyl 2-hydroxycarboxylic includes one or more of 2-hydroxylhexanoic acid or 2-hydroxydecanoic acid; from 0.002-1.75 weight percent of a sulfonated surfactant, wherein said sulfonated surfactant is one or more of alpha olefin sulfonate; hexyldiphenyl oxide disulfonate or ethyl hexyIdisulfonate; and water.